Status:
COMPLETED
Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?
Lead Sponsor:
University of South Carolina
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Drawing inferences from epidemiologic studies of HIV/AIDS as well well as cell culture and animal studies of HIV inhibition by algae, we propose algal consumption as one unifying characteristic of cou...
Detailed Description
Twelve HIV+ patients not on antiretroviral therapy were clinically evaluated and enrolled in the three-week study. Subjects received 10 algae capsules/d. Laboratory tests of CD4 counts and HIV RNA wer...
Eligibility Criteria
Inclusion
- Clinical diagnosis of HIV
- Able to swallow pills
Exclusion
- Allergy to iodine/seafood
- Thyroid disease
- Not taking antiretroviral therapy
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01195077
Start Date
February 1 2003
End Date
June 1 2008
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Prevention and Control Program/University of South Carolina
Columbia, South Carolina, United States, 29208